Tobacco Smoke and Asthma among Adults at the National and State Levels: Do Smoke-Free Laws and Regulations Affect Smoking Rate among those with Asthma? by Ibrahim, Mariam
Georgia State University
ScholarWorks @ Georgia State University
Public Health Theses School of Public Health
Summer 7-26-2013
Tobacco Smoke and Asthma among Adults at the
National and State Levels: Do Smoke-Free Laws
and Regulations Affect Smoking Rate among those
with Asthma?
Mariam Ibrahim
Georgia State University
Follow this and additional works at: https://scholarworks.gsu.edu/iph_theses
This Thesis is brought to you for free and open access by the School of Public Health at ScholarWorks @ Georgia State University. It has been accepted
for inclusion in Public Health Theses by an authorized administrator of ScholarWorks @ Georgia State University. For more information, please contact
scholarworks@gsu.edu.
Recommended Citation
Ibrahim, Mariam, "Tobacco Smoke and Asthma among Adults at the National and State Levels: Do Smoke-Free Laws and Regulations
Affect Smoking Rate among those with Asthma?." Thesis, Georgia State University, 2013.
https://scholarworks.gsu.edu/iph_theses/297
ABSTRACT 
Background: Asthma is a chronic lung disease that inflames and narrows the airways.  
This results in recurrent episodes of coughing, wheezing, shortness of breath, and chest 
tightness. Although the causes of asthma are poorly understood, genetic and 
environmental factors have been implicated in the development and exacerbation of the 
disease. Among environmental risk factors, cigarette smoke is a well-known risk factor to 
trigger asthma symptoms. Exposure to secondhand smoke irritates the airways and may 
trigger an attack in adults with asthma. Smoke-free laws and regulations in the United 
States differ by state. The enforcement of smoke-free legislation has been related to 
asthma rates as it has been shown that they lead to a sustained drop in emergency hospital 
admission for asthma among adults.  These laws and regulations are also necessary in 
reducing smoking rate and secondhand smoke exposure. 
Objective: The purpose of this thesis is to examine the association between tobacco 
smoke rates and asthma status among adults at the national and state levels and to 
evaluate the effects of state smoke-free laws and regulations on tobacco smoking rate 
among adults with asthma. 
Methods: The Centers for Disease Control and Prevention’s 2009–2010 Behavioral Risk 
Factor Surveillance System data was used for the analyses. SAS-callable SUDAAN 
(version 10.0.0, RTI International, NC) was utilized to account for the complex sampling 
design of the BRFSS, and sample weights were used to produce estimates that were 
generalizable to the state and U.S. adult population. In addition to calculating descriptive 
statistics, chi-square tests and multivariate logistic regression were used to test for group 
differences and association between variables of interest. State level smoking rates were 
ranked to identify states that are in the lower and upper 20th percentiles and compare 
them with states’ smoke-free laws and regulation status. 
Results were considered significantly different if 95% confidence intervals (CIs) did not 
overlap or if statistical testing at p<0.05 was applicable. 
Results: Asthma prevalence rates are higher among adults that smoke cigarettes (10.5%, 
[aPR] =1.2) compared to non-smokers (7.8%, [aPR] =1.0).  Of the 869,519 adult 
respondents in the survey, 8.5% reported having asthma.  Nearly one-fifth (17.2%) of 
adults without asthma smoked cigarettes, while (21.7 %) of adults with asthma smoked.  
Females (10.5%) had higher asthma prevalence rates than males (6.4%). Black persons 
(10.0%), persons of American Indian (13.0%) descent had higher, and those of Hispanic 
(6.7%) descent had lower asthma rates than white persons (8.6%). Adults with a high 
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school education or less (9.1%) had higher asthma rates than those with an education 
level that was equivalent to a 4 year college or more (7.3%) , and those with low income 
(<$15,000) had higher rates (13.3%) than those with high income (6.8%). Percentage of 
male (23.4%) and females (20.7%) with asthma who smoke are higher than those that do 
not smoke (19.3% and 15.1%, respectively).   
Asthma prevalence rates and smoking rates vary by geographic location. Smoking rates 
among adults with asthma was highest in the South (LA, AL, SC, TN, OK, MS, AR, WV, 
KY) and a couple of Midwest states (OH, IN,). Evaluating the association between the 
2008 State of Tobacco Control Report and smoking rate among adults with asthma by 
state showed a statistically significant relationship between smoking rate among adults 
with asthma and smoke-free policy and regulation at the state and national level.  On 
average, states with the lowest smoking rate among persons with asthma (smoking rates 
less than 20th percentile) had significantly higher smoke-free policy grades (mean grade 
[sd]=7.2 [1.99]) than states with a high smoking rate (smoking rate of 80th percentile or 
more) (mean grade [sd]=2.0 [2.00]) (p-value < 0.00001). 
Conclusion: Although most U.S. state smoke-free policies and regulations are relatively 
new, it is evident that these laws are effective in promoting cessation among adults and 
reducing nonsmokers’ exposure to secondhand smoke.  The study found that smoke-free 
laws may improve health by lowering asthma prevalence and smoking rates among adult 
smokers.  Also, these policies in turn protect non-smokers from the harmful health effects 
of secondhand smoke. 
 
Key Words: asthma, asthma prevalence, cigarette smoke, adults, smoke free policy 
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CHAPTER I 
 
INTRODUCTION 
 
1.1 Background 
Asthma is a respiratory disease that attacks the airways in the lungs; this chronic 
inflammatory condition affects more than 25 million Americans (Centers for Disease, 2011).  
Trends in current asthma prevalence rates have been on the rise with an estimated 16.5% 
increase from 7.3% in 2001 to 8.5% in 2010 (Centers for Disease, 2011).  The previous Centers 
for Disease Control and Prevention (CDC) reports indicate significant differences in asthma 
prevalence between many population subgroups.  While differences exist between the 
demographic subgroups- children, adults, males, females, whites, blacks, and Hispanics- there 
has been a rising trend in asthma prevalence across all subgroups over the past few decades.  For 
instance, analyses of trends for 2001-2010 for current asthma prevalence for population-based 
rates show that in 2010, females had higher prevalence than men (9.7% compared with 5.7%); 
this prevalence rate has been increasing at a rate of 1.8% per year among males and females 
(Centers for Disease, 2011).  The rise in the asthma prevalence rates creates a substantial health 
and economic burden on individuals and society (Hahn, 2010).  It is estimated that the mean 
annual per capita healthcare expenditure for asthma related cases in 2006 was $5,322 (in 2010 
US dollars) (Rank, 2012); total cost estimate of asthma to the United States was $56 billion in 
2007 (Barnett, 2011). 
Science has not found a cure for asthma.  The causes of asthma are poorly understood as 
multiple factors (genetic predisposition, environment, gene-environment interactions) play a role 
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in the development and worsening of asthma symptoms (Grassi, 2006;Ober, 2005;Willemsen, 
2008;Yang, 2007).  However, the rise in asthma in recent years cannot be attributed to changes 
in genetic factors.  Instead, intervention efforts to halt the increasing asthma prevalence should 
be redirected to focus on environmental factors.   
Cigarette smoking and secondhand smoke are among the main environmental triggers of 
asthma.  Even though it is known that smoking aggravates asthma symptoms, a higher 
percentage of adults with asthma smoke when compared to the percentage of adults without 
asthma that smoke (Table 3).  The combination of asthma and active cigarette smoking results in 
more pronounced asthma symptoms, accelerated decline in lung function, and reduce the body’s 
response to corticosteroid treatment (asthma medication) (Levy, 2002). 
Smoke-free laws effectively reduce smoking and secondhand smoke exposure.  In addition, 
smoke free legislation is shown to improve indoor air quality, increase the likelihood of smoke 
cessation and lower the rates of asthma exacerbations (Hahn, 2010;Jill S. Rumberger, 
2010;Levy, 2002). It has been noted that aside from the health outcomes, smoke free legislation 
does not negatively affect employment or business profits (Haw, 2007;Prevention, 2007).  
Smoke free legislation is an important step that needs to be taken into account by public officials 
as a public health intervention strategy that reduces the long-term health and financial burden of 
cigarette/tobacco use. Asthma is a long-term disease that cannot be cured but through policy 
changes it can be relatively controlled and managed in order for individuals to live normal, active 
lifestyles (Centers for Disease, 2011).   
1.2 Purpose of Study 
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The purpose of this study is to investigate the relationship between the prevalence of smoking 
and secondhand smoking exposure among adults with asthma by analyzing data from the 2009-
2010 Behavioral Risk Factor Surveillance System.  In addition, the impact of smoke-free policies 
on smoking prevalence among adults with asthma was examined by studying The American 
Lung Association State of Tobacco Control 2008 report that tracks progress on key tobacco 
control policies at the state and federal level and assigns grades to tobacco control laws and 
regulation enacted as of January 1, 2009 (Association, 2012). The results of this study bring light 
to whether smoke-free policies are cost effective in terms of reducing the annual direct 
healthcare cost of asthma and the indirect cost measured by lost work days (Association, 2012). 
1.3 Research Questions 
The purpose of this study is to gather data from the Behavioral Risk Factor Surveillance 
System (BRFSS) and the American Lung Association State of Tobacco Control report in 
order to answer the following questions: 
I. What is the current asthma prevalence rate and factors associated with it? 
II. What is the percentage of smokers by asthma status, selected demographic characteristics 
and state? 
III. What is the impact of state wide smoke-free laws on smoking rates among persons with 
asthma? 
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
2.1 State of Asthma Defined 
Asthma continues to be a major public health concern in the United States and worldwide.  
Asthma is a chronic and life-threatening disease that affects 25 million people in the U.S. and 
235 million people around the world, according to the World Health Organization, 2012(To, 
2012).  In the U.S. asthma affects nearly 8% of the adult population and 9.5% of children aged 0-
17 years.  Projections speculate that by year 2025, the number of people worldwide with asthma 
will increase to 400 million, a 70% surge, as countries become more urbanize (To, 2012).  The 
increase in prevalence poses a substantial concern in terms of the health and financial burden that 
the disease has on the general population and the country.  In order to tackle the complexities of 
asthma, additional research is needed to understand the causes of asthma. 
In asthma patients the airways in the lungs become inflamed which makes the airways 
sensitive; certain irritants cause the airways to tighten, become smaller and produce extra mucus; 
when the airways become obstructed the air flow to the lungs decreases making it harder to 
breath (Piipari, 2004).  Asthma presents itself with the following respiratory symptoms: 
wheezing, coughing, nocturnal chest tightness, shortness of breath or attacks of breathlessness 
following activity, and chest tightness particularly at night or early in the morning (Cerveri, 
2012).  The airway obstruction that characterizes asthma is reversible and patients with this 
disease respond to corticosteroid therapy whether inhaled or orally (Cerveri, 2012).   
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At present, there is no known cure for asthma but people with asthma can be symptom free 
for days, even years with an affective asthma management and control (National Asthma, 2007 
#111).  The National Asthma Education and Prevention Program (NAEPP) was established in 
1989 to address the asthma-related prevalence and mortality rates and to enhance the lives of 
persons with asthma.  NAEPP convenes a panel of expert to perform a systematic review of all 
published scientific literature and report new finding or confirm that current asthma guidelines 
reflect scientific advances.  This panel of 18 experts is independently appointed by the NAEPP 
and prepares a report, Expert Panel Report 3-Guidelines for the Diagnosis and Management of 
Asthma (EPR-3), that examines the up-to-date scientific progress made in the field of asthma 
control and management (National Asthma, 2007).  Based on EPR-3, an affective asthma 
management consists of four components:  
1. Assessment of asthma severity and control, there are two domains (National Asthma, 
2007): 
a. Assessment of impairments 
With regards to assessing asthma severity, physicians are required to examine the 
symptoms and lung function of current impairment.  In evaluating asthma impairment, the 
following symptoms are taken into consideration: daytime symptom, awakening at night, the 
need for inhaled Short-Acting Beta2-Agonists (SABA) for quick relief of symptoms, missing 
work or school days, the inability to engage in normal day-to-day activity and a quality-of-life 
assessment (National Asthma, 2007). 
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In terms of lung function, a spirometer classifies severity by measuring the forced 
expiratory volume in 1 second (FEV1), the forced expiratory volume in six seconds (FEV6) in 
adults, and the forced vital capacity (FVC) (Fuhlbrigge, 2001).  The use of this tool has been 
found effective in cross-sectional and longitudinal studies of children that provided proof of an 
association between severity of airflow obstruction and the risk of exacerbations (Fuhlbrigge, 
2001).  These studies report FEV1 to be useful in indicating risk for exacerbations; while 
FEV1/FVC is a more accurate measure of severity in the impairment domain (National Asthma, 
2007). 
Aside from examining the effects of asthma on the quality of life and current functional 
capacity on an ongoing basis, we also need to assess the risks asthma presents for adverse events 
in the future. 
b. Assessment of risk for future exacerbation (National Asthma, 2007) 
The second part of assessing asthma severity and controlling it is to measure the future risks 
that asthma may present.  These adverse events include exacerbations of asthma presented by 
episodes of progressively deteriorating shortness of breath, wheezing, chest tightness, and cough-
and the risk of death.   
Patients found to be at a high risk of future exacerbations are closely monitored and will need 
to undergo periodic assessments by their physicians.  Depending on the frequency and intensity 
of exacerbations (measured by hospitalization, ICU admission, or unscheduled clinical care), 
several interventions are to be considered (discussed in the following three asthma management 
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components).  To reduce risk, clinicians focus on avoiding frequently occurring exacerbations of 
asthma and reducing the need for ED visits or hospitalizations (National Asthma, 2007).  Also, 
they work to stop the progressive loss of lung function especially in children.  Finally, they 
present patients with options of prescriptive medicine with minimal or no side effects.  
2. Education for people with asthma and those that provide asthma care (National 
Asthma, 2007) 
EPR-3 provides recommendation on asthma self-management education at multiple points of 
care, tools for asthma self-management, and provider education.  It is believed that specialized 
training in self-management is essential in creating behavior that modifies the outcomes of 
chronic illnesses such as asthma.  Educating persons with asthma in self-management skills of 
‘self-assessment, use of medications, and actions to prevent or control exacerbations’ will result 
in ‘reduction in urgent care visits and hospitalizations, reduction of asthma-related care costs, 
and improvement in health status’ (National Asthma, 2007, p.96) 
3. Control of environmental factors and co-morbid conditions that affect asthma (National 
Asthma, 2007) 
Evidence has shown a strong association, in people who have asthma, between exposure to 
allergens and an increase in asthma symptoms and exacerbation of the disease (EPR-3).    EPR-3 
notes that reducing exposure to indoor and outdoor inhalant allergens to which the patient is 
sensitized can improve asthma control.  The report recommends an action plan for effective 
indoor and outdoor allergen avoidance in a multifaceted approach. 
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4. Appropriate medical treatment (National Asthma, 2007) 
Among medical treatment there are two types of asthma medications: quick relief 
medications provide prompt relief of symptoms and long-term control medications prevents 
symptoms by reducing inflammation. Quick-relief meds are to be taken as needed when asthma 
symptom exacerbations occur, they do not provide long-term asthma control.  On the other hand, 
to control asthma symptoms long-term patients need to take long-term control medication daily 
regardless of experience in symptoms.  Corticosteroids are the first and most common choice of 
long-term controller medications (National Asthma, 2007). 
Corticosteroids is an anti-inflammatory treatment that suppresses the inflamed airways ‘by 
inducing the recruitment of the nuclear enzyme histone deacetylase 2 (HDAC2) to multiple 
activated inflammatory genes, which leads to deacetylation of the hyperacetylated genes, thereby 
suppressing inflammation’ (Barnes, 2008, p.7). Several studies confirm that the regular 
administration of corticosteroids have been found to reverse the airway obstruction and 
inflammation caused by the disease (Fuhlbrigge, 2001;Piipari, 2004). 
 
2.2 Risk Factors 
Asthma is a condition that is complex with genetic as well environmental components.  
Researchers believe that exposure to a number of factors (genetic, environmental) and 
interactions between these factors are association with the exacerbation of asthma-like symptoms 
and the development of the disease (Grassi, 2006;Ober, 2005;Willemsen, 2008;Yang, 2007). 
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Other host-related factors have also been found to be associated with the occurrence of 
asthma in adults and children.  Elements that are considered host-related include the age of the 
patient, their sex, race, ethnicity, smoking status, and obesity.  Co-morbid conditions such as 
gastro-esophageal reflux disease [GERD] and chronic sinus disease have been shown to have a 
link to asthma (Pearlman, 2009).  These host-related factors are classified as modifiable 
(education, income, health insurance status, smoking, obesity, and co-morbid conditions) (Beane, 
2007;Gwynn, 2004;Services, 2006;Strine, 2004) and non-modifiable (e.g., heredity, age, sex, 
race, and ethnicity) (Gwynn, 2004;Strine, 2004;Willemsen, 2008).   
 Previous studies show that differences in life experiences (e.g. family, social, and economic 
environment), lifestyle choices (smoking, obesity, leisure time physical activities), and exposure 
to adverse indoor and outdoor environment factors (e.g., mold, pollens, house dust mites, 
cockroaches, rodents, animal allergens, environmental tobacco smoking [ETS], and other air 
pollutants) may account for some of the racial and ethnic differences in asthma prevalence 
(Committee on the Assessment of Asthma and Indoor Air, 2000;Gwynn, 2004;Strine, 2004).  
Even though previous studies have identified potential predictors of asthma, specific information 
about the predictive factors among racial and ethnic groups has been limited. These study 
findings were limited to either a few major race/ethnic groups (e.g., white vs. non-white or 
whites vs. blacks, Hispanics, and other race) or predictive factors were examined by controlling 
for the effects of race/ethnicity.   
The potential determinants of asthma vary on a broad spectrum that ranges from genetic 
history to environmental factors. 
10 
 
 
 
Genetic 
While genetic predisposition may result in the development of allergies (eczema or hay 
fever) and asthma, the genotype of asthma is multifactorial and positive family history does not 
necessarily predict the presence of the disease (Pope, 2002).  Gene studies have found the 
presence of age-specific genetic effects (Dijk, 2013;Forno, 2012;Henderson, 2009).  Several 
published studies and meta-analysis show genome-wide association for childhood and adult 
asthma, obtaining genetic associations at a genome-wide significant level, either in the original 
cohort, the replication cohort, or in a combined analysis. It is estimated that at least 40 genes 
were found to be associated with the development of asthma; replication studies in independent 
populations confirm these findings (Forno, 2012).   
In the US, a study on an original population of Non-Hispanic whites found that the presence 
of the gene, PDE4D, had a strong association with the development of asthma in children and 
adults (Himes, 2009). The PDE4D sequence works to constrict the airways smooth-muscle cells, 
leading to asthma.  The same study was replicated using African-Americans, European 
Americans, US Hispanics, and British and resulted in the same finding. However, the presence of 
PDE4D in the African-American population had no association with the development of asthma 
in adults or children (Forno, 2012;Himes, 2009). 
Other findings in gene variants are essential in understanding the role of genetics in asthma 
pathophysiology and the effectiveness of certain gene inhibitor medications.  Henderson et al. 
confirms that in order to find solutions to questions about the cause of asthma, we have to 
maximize our knowledge on genome-wide linkage to asthma (Dijk, 2013).  To increase our 
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understanding of the etiology and natural history of asthma, ‘it is important to consider the 
impact of precise classification of phenotypes on issues such as replication of associations, 
misclassification bias and harmonization of outcomes across populations large enough to achieve 
sufficient statistical power, particularly for the detection of gene-gene and gene-environment 
interactions’ (Henderson, 2009). 
Demographic 
Predictors of asthma differ by sex, race/ethnicity, age, education, income, and smoking 
status.  Asthma disproportionately affects certain demographic groups, and the disproportionate 
impact has persisted over time (Frieden, 2011;Prevention, 2007;Centers for Disease, 2011).  
Current asthma prevalence is higher among women than men and among children (9.5%) 
than adults (7.7%) (Subbarao, 2009).  In women, asthma prevalence is 9.2% compared to 7.0% 
for men.  Subbarao et al., summarizes the findings of several research papers by reporting that in 
women airway hyper responsiveness increases in female in adulthood compared to men making 
them more susceptible to developing asthma.  At puberty the incidence and prevalence of asthma 
starts to switch from being higher in boys to becoming higher in girls (Subbarao, 2009).  Studies 
have been unable to find any scientific evidence that pubertal development is a resultant of 
asthma occurrence.  This shift in the occurrence of asthma appears between the sexes during the 
first and second decades of life and during the fifth or sixth decades (Subbarao, 2009). In other 
words, before the age of 10 or mid-teen years, boys have higher frequency of asthma than girls.  
While no scientific evidence shows interference between puberty and asthma occurrence, after 
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puberty girls asthma rates starts to rise surpassing the rates of boys.  However, investigations 
found that in general occurrence of asthma decreases with age in both sexes.   
Aside from the gender differences in asthma prevalence, other selected characteristics 
affect the rates of asthma.  For instance, asthma prevalence differs by race, ethnicity, poverty 
status, geographic region and urbanicity.  Trends in population-based asthma prevalence by race 
and ethnicity show the interaction between prevalence rates and how they relate to these two 
factors.  In the United States, the average annual 2008-2010 asthma  prevalence was higher 
among blacks (11.1%), American Indian or Alaska Native (AI/AN) (8.8%) , persons of multiple 
race, and lower among Asian (5.3%)  and Hispanics (6.3%)  than whites  (7.3%) (Gwynn, 
2004;National Asthma, 2007;Prevention, 1999;Prevention, 2000;Smith, 2005;Strine, 2004).  
Compared with non-Hispanic white and non-Hispanic black persons, current asthma prevalence 
is higher among Puerto Rican and lower among Mexican persons.   
The National Health Interview Survey (NHIS) shows that family income along with 
geographic region and urbanicity play an important role on asthma prevalence.  Those with 
family income below the federal poverty threshold (11.2%) have higher current asthma 
prevalence rates compared to persons with family income at or above the federal poverty line 
(8.5%) (Akinbami, 2012).  Combining this finding with the examination of geographic region, 
analysts found that prevalence is higher in the Northeast (8.8%) than in the West (8.0%) and 
South (7.6%) and in the Midwest (8.7%) compared to the South (7.6%) (Akinbami, 2012).  
However, when prevalence rates for urbanicity were examined, current asthma prevalence did 
not differ between metropolitan and nonmetropolitan areas. 
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Environmental  
Among the factors that affect the current asthma status are seasonal and non-seasonal 
allergens such as cockroaches, dust mites, mold, pets and animals, pollen, and other air 
pollutants and asthma irritants such as cigarette smoke (Huss, 2001).  The National Institutes of 
Health (NIH) and the Environmental Protection Agency (EPA) funded a 2-year study that found 
a strong relationship between modestly increasing the levels of air pollution and elevated 
frequency of asthma symptoms and lower lung function (Pope, 2002). These environmental 
factors affect a person’s life differently and an individual’s reaction to them may change over 
time.   
Indoor air pollution: (smoke, mold, cigarette, noxious fumes, cleaning products, paints) have 
been found to help in the development of allergic reactions and asthma, especially in children.  
Exposure to certain air pollutants such as O3, PM10, CO, SO2 and NO2 have been linked to an 
increase in asthma symptoms (Agrawal, 2012;Huss, 2001;Mishra, 2002).  Studies have found 
that a main source of indoor pollution is cooking smoke, which is the product of biomass and 
solid fuel combustion used in developing countries.  Exposure to cooking smoke and tobacco 
smoke indoors increases the severity of asthma attacks, reduces the efficacy of treatments, and 
worsens the decline of lung functions (Agrawal, 2012;Huss, 2001;Mishra, 2002). 
The most commonly research topics that are thought to be related to the onset of asthma are 
exposure to house dust mites, cockroach and pet-derived allergens. Exposure to mite and 
cockroach allergens early in life and in homes causes children to become increasingly sensitized. 
A study that examined the   found that 88% of patients that were exposed furred or feathered pets 
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in the house tested positive for allergy skin tests which have been associated with asthma 
morbidity (Huss, 2001).  In the United States, the strongest risk factors associated with the 
development of asthma are sensitization to dog and cat allergens (Huss, 2001).  Studies have 
found that avoidance of allergens early in life helps prevent sensitization. 
Outdoor air pollution: the two commonly described air pollutants that can affect health and 
are monitored by the U.S. Environmental Protection Agency (EPA) are particulate matter and 
ozone (Girardot, 2006;McConnell, 2002).  Particulate matter are solid or liquid particles 
suspended in the air and can be man-made (e.g., smoke, fumes, soot, and combustion by 
products) or natural (e.g., windblown dust, volcanoes, agricultural crops, forest fires, pollen, and 
sea salt) (Brook, 2010;Dockery, 2009;Pope, 2006).  The relationship between exposure to 
concentrated outdoor particulate matter and adverse health effects includes lung cancer, 
premature death, exacerbation of respiratory and cardiovascular disease (e.g., asthma and 
COPD), and increased risks for cardiovascular morbidity (e.g., myocardial infarction and 
arrhythmia) (Brook, 2010;Dockery, 2009;Pope, 2006).  
Ozone, the second well-characterized air pollutant, is the most abundant photochemical 
oxidant (Hoppe, 2003).  This atmospheric pollutant when inhaled exacerbates asthma and lessens 
the ability of the lungs to eliminate infectious agents and toxins (Girardot, 2006;McConnell, 
2002).  At ground level, ozone appears as urban smog and affects people with outdoor 
occupations, athletes and sensitive groups (children, elderly, asthmatics or people with other 
respiratory or cardiovascular disease) (Girardot, 2006;Hoppe, 2003;Triche, 2006). 
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Research on the topic of asthma development provides no consensus on whether 
environmental factors directly result in the development of asthma or only trigger asthma 
symptoms (Beane, 2007;Institute of Medicine, 2000;Frieden, 2011).  Different approaches to 
prevent and treat asthma continue to be studied.  
 
2.3 Smoking and Asthma 
Tobacco smoke is one of well-known risk factors for asthma.  Persons with asthma are more 
sensitive to the toxic chemicals and irritants that are brought about by cigarette smoke.  Piipari el 
al reported that the risk of developing asthma was significantly higher among current smokers 
and among former smokers compared with those who have never smoked (OR, 1.33 and 1.49 
respectively) (Piipari, 2004).  Sufficient evidence supports that exposure to secondhand tobacco 
smoke, also known as environmental tobacco smoke (ETS) causes exacerbation of asthma 
symptoms among preschool age children (Institute of Medicine, 2000). 
Similar to asthma the common symptoms of smoking are wheezing, coughing, shortness of 
breath, nasal congestion, and burning or watery eyes.  Among the environmental factor of 
asthma, cigarette smoking and secondhand smoke are important triggers (Cerveri, 
2012;Stapleton, 2011;Piipari, 2004).  Tobacco smoke increases inflammation and mucus 
secretion in the airways which leads to worsening asthma symptoms, more airway inflammation, 
and reduces response to inhaled corticosteroid treatment, and an accelerated decline in lung 
function (Institute of Medicine, 2000;Piipari, 2004).  It is well documented that exposure to 
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tobacco smoke or prolonged periods in asthmatic patients contributes to a decline (estimated 
18%) in lung function (Institute of Medicine, 2000;Piipari, 2004).   
Furthermore, studies have found that patients with asthma that smoke or are exposed to 
second hand smoke respond poorly to corticosteroid treatments.  In cases where patients had 
severe asthma, increasing the dosage of inhaled or oral corticosteroids failed to suppress 
inflammation (Barnes, 2008).  This is the result of corticosteroid resistance that is believed to be 
linked to impaired nuclear enzyme histone deacetylase 2 (HDAC2) functions (Barnes, 2008).  As 
noted, the prevalence of smoking among adults has introduced additional complications to a 
chronic disease that continues to affect the lives of a growing population. 
Tobacco smoke contains more than 4,000 toxic substances (Spira, 2004).  Irritating 
substances settle in the moist lining of the airways (tar, carbon monoxide, nicotine, and more) 
causing inflammation and increasing mucus secretion (Spira, 2004). Very few studies have been 
done in humans to establish the effects of smoking on epithelial cells of the pulmonary airways 
(Spira, 2004).  Spira et al. has found that cigarette smoking decreased the functionality of several 
tumor suppressor genes and genes that regulate airway inflammation.  Another adverse outcome 
of smoking is that it damages cilia in the airways.  Cilia are microscopic hair-like projections 
lining the epithelial cells that sweep dust and mucus out of the airways keeping them free from 
infection; a process called mucociliary clearance (Leopold, 2009).  The harmful toxins present in 
tobacco smoke paralyzes the cilia cells allowing dust and mucus to accumulate in the airways, as 
a result, more mucus can build up in the airways, triggering an asthma attack (Krieger, 
2001;Leopold, 2009)  Leopold et al. has shown that smoking not only inhibits the movement of 
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cilia cells, but is also associated with the average shortening of airway epithelial cilia (by 13%) 
which further reduces efficacy (Krieger, 2001).  Long-term smoking will result in the 
progressive destruction of cilia and thus a decrease in mucociliary clearance making smokers 
more vulnerable for developing smoking-induced lung disease. However, depending on prior 
smoking habits, the lungs have the ability to heal and smoking cessation allows the cilia to re-
grow and resume functioning within 2 years.  Studies that examined effects of smoking cessation 
have found that genes serving metabolizing and antioxidant functions reverted to normal levels 
within 2 years, while tumor suppressor genes failed to return to never smoker levels after 
quitting.  Leopold et al. concludes that this finding may provide the rationale for ‘the continued 
risk for developing lung cancer many years after individuals have ceased to smoke’ (Leopold, 
2009). 
 
2.4 Smoke free Legislation- health and economic outcomes 
Effective smoke-free legislation is among the most fundamental public health intervention 
measures that could reverse the adverse health effects of smoking.  Research has shown that 
when a comprehensive smoke free law is effectively implemented, the entire population gains in 
terms of health benefits.   Studies conducted in a number of countries (Canada, Italy, Ireland) 
have shown a significant reduction in the levels of people reporting exposure to second hand 
smoke.  Also found as a result of smoke free legislation was a decline in respiratory/sensory 
symptoms, emergency department visits for asthma among children and adults (18% for 
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children, 24% for adults).  Interestingly, in Ireland, emerging research has found that 1 year after 
implement a smoking ban in the workplace, the risk for preterm birth declined by 25% and the 
rate of maternal smoking decrease by 12% (Kabir, 2009).   
Aside from the positive health outcomes of smoke-free legislation, the American Lung 
Association release a study conducted by researchers at Penn State University that analyzed the 
nationwide cost-benefit of smoking cessation treatments.  The researchers found that smoking 
costs the nation a combined annual $301 billion in lost productivity ($67.5 billion), premature 
death ($117 billion), and health care expenditure ($116 billion) (Jill S. Rumberger, 2010).  The 
researchers concluded that depending on the smoking cessation counseling method, the return on 
investment for the state could be up to 87% (Jill S. Rumberger, 2010). 
Several strategies have been implemented and studied in an effort to reduce smoking 
prevalence.  The most common intervention is a comprehensive smoke free-state wide program, 
banning smoking in public places, increasing the tax on cigarette sales.  In Washington State, 
Dilley et al. examined the health effects associated with tobacco control interventions (program, 
policy, and price intervention for tobacco) to quantify the return on investment (Dilley, 2012).  
This study was the first of its kind to investigate the association between multiple specific health 
conditions (Ischemic heart disease hospitalizations, cerebrovascular disease hospitalizations, 
chronic respiratory disease hospitalizations, esophageal cancer incidence, larynx cancer 
incidence, oral cancer incidence, and lung cancer incidence) and multiple proven tobacco control 
interventions (comprehensive state program, state policy banning smoking in public places and 
price increases) (Dilley, 2012).  The findings of the study concluded that the tobacco control 
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interventions worked to lower hospitalization rates and would save the state of Washington an 
estimated $1.5 billion in hospitalization.   
Smoke-free legislation 
National Health Service (NHS) statistics analyzed by researchers in Scotland found that the 
introduction of smoke-free legislation resulted in a reduction to exposure to secondhand smoke 
among nonsmokers living in nonsmoking household (Haw, 2007).  Haw et al. measured the 
amount of cotinine, an alkaloid found in tobacco, concentrations by collecting saliva samples 
from smokers and nonsmokers.  Then, the researchers compared the cotinine measurements in 
the respondents prior to the smoke-free legislation and a year following it (Haw, 2007).  The 
overall geometric mean cotinine for nonsmokers living in nonsmoking households fell by 49% 
(P-value less than 0.001).  This significant reduction in exposure to secondhand smoke observed 
in Scotland, leads the researchers to believe that smoke-free legislations may produce immediate 
health gains as well as a reduce  morbidity and mortality related to second-hand smoke(Haw, 
2007).  What the study adds to research in the topic of smoke-free legislation effects on the 
population is that the main beneficiaries of the legislation are non-smokers living in non-
smoking homes as exposure to secondhand smoke was reduced in all public places and 
workplaces but not in homes and private cars.  
Cigarette tax 
In the ongoing debate to lower smoking prevalence, cigarette tax is the most commonly 
advocated means to reduce smoking.  Legislative interventions to increase the price of cigarettes 
have been found to discourage young adults from starting smoking as well as reducing the 
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average cigarette consumption among current smokers (Services, 2005;CDC, 2000;Medicine, 
2007)  In 2009, the United States placed a 15% federal tax increase on the average pack of 
cigarette price with a proposed additional average increase of 34%.   Researchers at the 
University of Illinois at Chicago measured the immediate impact of excise tax increase on youth 
through May 2009 by using the Monitoring the Future survey, a national representative survey of 
8th, 10th, and 12th grade students (Huang, 2012).  Huang et al. found that the 62 cent-a-pack 
increase resulted in an estimated average drop of 11.5%. 
Martire et al. performed a study in Australia that compares the possible impacts of proposed 
price increases on smoking prevalence in both the United States (U.S.) and Australia.  The 
researchers examine the effects of the proposed tax increases (U.S. - 34%, Australia- 49%) as 
well as the probable effect of financial stress (Martire, 2011).  The findings of the paper suggest 
that the increase in tobacco tax will potentially lower the prevalence in both countries.  
Implementation of tax increases was found to decrease smoking in lower socioeconomic status 
groups by 2% in the U.S. and 8% in Australia.  However, by taking into account the effects of 
financial stress, Martire et al. found that smoking prevalence was reduced by 0.13% in the U.S. 
and 0.36% in Australia (Martire, 2011).  Therefore, the researchers believe that instead of 
tacking this issue from one standpoint of taxing cigarettes, instead ‘policy makers need to 
interrupt the negatively reinforcing cycle of smoking and financial stress’ by ‘providing free or 
subsidized smoking cessation resources to reduce the economic burdens borne by financially 
stressed smokers and facilitate quitting.’ (Martire, 2011, p.628) 
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CHAPTER III 
 
METHODOLOGY 
3.1 Data Source 
The Centers for Disease Control and Prevention’s 2009–2010 Behavioral Risk Factor 
Surveillance System (BRFSS) data was used for the analyses. SAS-callable SUDAAN (version 
10.0.0, RTI International, NC) was utilized to account for the complex sampling design of the 
BRFSS and sample weights were used to produce estimates that were generalizable to the state 
and U.S. adult population.  
BRFSS is a joint partnership project with the Centers of Disease Control and Prevention 
(CDC) and U.S. states and territories (William J. Curry, 2010).  BRFSS is an ongoing state-
based, random-digit dialed telephone survey of the non-institutionalized U.S. population, aged 
18 years of older.  The main purpose of the BRFSS is to gather uniform and state-specific data 
on preventive health practices and risk behaviors that are linked to chronic diseases, injuries, and 
preventable infectious diseases in the adult population.  The data collection process of the 
BRFSS is administered by state health departments with guidelines provided by CDC.  The 2009 
and 2010 BRFSS was conducted in the 50 states, the District of Columbia (DC), Puerto Rico 
(PR), the U.S. Virgin Islands, Guam, American Samoa, and Palau (CDC, 2011).  However, we 
limited our analysis to 50 states and, the District of Columbia (DC). This survey is the world’s 
largest ongoing survey with over half a million interviews conducted annually.   
In order to have a representative sample of the population, BRFSS uses a statistical method 
called post stratification (CDC, 2011).   In post stratification, after data has been collected, data 
is compare it to an auxiliary data set representation of the population to make sure that the 
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distributions of demographic characteristics (age, race and ethnicity, sex, geographic region 
within a population.) are within a few percentage points (Gelman, 2000).  If the collected data 
differ by more than the accepted range of percentage points, the sample data is adjust to conform 
to the population’s parameters.   
BRFSS measures personal behaviors that put an individual’s health at risk.  To determine 
current cigarette smoking, respondents are asked, “Have you ever smoked at least 100 cigarettes 
in your entire life?” and “Do you now smoke cigarettes every day, some days, or not at all?" 
Current smokers are defined as those who reported having smoked >100 cigarettes during their 
lives and who currently smoked every day or some days (CDC, 2011). Because BRFSS data is 
state-specific, median values rather than a national average are reported.  Topics included in the 
BRFSS questionnaire that has to do with demographic data include: age, sex, ethnicity, race, 
marital status, education level, employment status, income, county of residence, pregnancy status 
and children less than 18 years in household (CDC, 2011).  
Response rate is an outcome rate with the number of complete and partial interviews in the 
numerator and an estimate of the number of eligible units in the sample in the denominator.  To 
account for respondents accurately, the BRFSS uses the Council of American Survey Research 
Organizations (CASRO) rates (CDC, 2011).   Response Rate calculation assumes that the 
unresolved numbers contain the same percentage of eligible households as the records whose 
eligibility or ineligibility are determined.  Therefore, the BRFSS uses proportions of unknown 
households in each of the states to estimate the total number of households from those whose 
eligibility is undetermined (CDC, 2011)  In 2009, the median response rate was 52.48% (does 
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not include Guam, Puerto Rico or the Virgin Islands) and  in 2010 the median response rate was 
54.60% (CDC, 2011). 
To assess smoke-free policies, we used the American Lung Association State of Tobacco 
Control 2008 report that follows state and federal policy advancements on important tobacco 
control policies and allocates grades to tobacco control laws and regulation enacted as of January 
1, 2009.  The ALA State of Tobacco Control accounts for laws enacted by January of 2009, so 
when individuals were surveyed in 2009 and 2010 and asked about their smoking status their 
answers were dependent on the effects of existing laws, which was put into effect in the prior 
year. The federal government along with all 50 states and the District of Columbia are evaluated 
and graded to establish whether or not tobacco control laws are effective in protecting citizen’s 
health against tobacco use and reducing the economic cost of tobacco on society (CDC, 2012). 
The American Lung Association State of Tobacco Control report evaluates both state and federal 
policies in four main areas:  smoke-free air, tobacco prevention and control funding, cigarette 
taxes and cessation coverage (Association, 2012).  The calculation of state grades for tobacco 
prevention and control spending is based on the Centers for Disease Control and Prevention’s 
(CDC) published Best Practices for Comprehensive Tobacco Control Programs (Association, 
2012).   The smoke-free air laws grading is based on criteria developed by an advisory 
committee convened by the National Cancer Institute with some modification to reflect the 
current policy environment.  The grading for state cigarette excise tax is based on the average of 
all state taxes; the grades are adjusted annually to reflect the change in the average tax increase.  
Finally, the state cessation coverage grading system is based on the U.S. Department of Health 
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and Human Services’ published Clinical Practice Guideline on Treating Tobacco Use and 
Dependence.   
3.2 Study Measures 
 Consistent with previous CDC reports, two asthma prevalence questions are being used 
by BRFSS as a measure of asthma data.  First, an affirmative response to the question “Have you 
ever been told by a doctor {nurse or other health professional} that you have asthma?’ defines a 
status of lifetime asthma (CDC, 2011).  Second, current asthma is defined as an affirmative 
response to the previous question followed by an affirmative response to the following question, 
“So you still have asthma?”  Responses to these two questions are tabulated for adults for various 
demographic groups.   
To provide more meaningful results that are specific to unique groups, the analyses were 
stratified related to current health conditions (asthma) and risk factors according to the following 
characteristics: gender, age group, race, education, income and smoking status.  We categorized 
gender is to two groups (male/female); age in to four groups  (18-34/35-44/45-64/65+); race in to 
six groups (White/Black/American Indian/Alaskan Native/Hispanic/Other race); education into 
three groups (high school education or less/some college/college 4 years or more); income into 
five groups (<15000/15000-24999/25000-49999/50000-74999/ 7500); and smoking into three 
groups (current smoker/former smoker/ non-smoker) (Table 1).  These categories were chosen 
because of the assurance of a reasonable sample size in each category.  The data were analyzed 
specifically for adults with asthma and adults without asthma. 
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The American Lung Association State of Tobacco Control report evaluates both state and 
federal policies by comparing them against targets based on the most current, recognized criteria 
for effective tobacco control measures, and translating each state’s relative progress into a letter 
grade of A through F (CDC, 2012). A grade of “A” is assigned for excellent tobacco control 
policies while an “F” indicates inadequate policies.  The American Lung Association (ALA) 
tracks four components to grade states: 
1. Tobacco Prevention and Control Spending 
2. Smokefree Air 
3. Cigarette Excise Tax 
4. Cessation Coverage 
For this study we used three of the four components because ‘Tobacco Prevention and Control 
Spending’ did not change much among states.  To examine the association between state of 
tobacco control efforts and smoking rate among those with asthma, we summed for each of the 
three components for each state to obtain overall policy grade for each state as shown in Table 5.  
The overall policy grade was used because it accounts for the cumulative effects of all three 
important laws selected:  
1. Smoke-free air for its effects on reducing secondhand smoke in homes, work or 
restaurants, 
2. Increased cigarette excise tax for discouraging people who smoke as well as reducing 
exposure to secondhand smoke. 
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3. Smoking cessation programs for encourage people who smoke to quite will improve 
smokers’ health and also will reduce exposure to secondhand smoke.  As evident in 
literature, the adverse health outcomes of smoking such as worsening asthma symptoms, 
emphysema, chronic bronchitis, and risk of cancer can be substantially reduced the 
sooner individuals quit smoking. 
3.3 Analysis 
The BRFSS dataset was obtained electronically and downloaded into SAS-callable 
SUDAAN (version 10.0.0, RTI International, NC) for analysis.  Alpha levels of <0.05 was used 
for all statistical significance testing.  Multivariate analyses were performed to reveal descriptive 
statics regarding the study population.  These analyses categorized and identified frequencies and 
central tendencies around age distribution, race/ethnicity, education level of respondents, income 
as well as smoking status (Table 2). 
Multivariate logistic regression (dependent variable is Asthma- Yes/No) analysis was 
also used to examine the association between demographic characteristics (age, sex, race, 
ethnicity, education, income), smoking status, and asthma status (Table 2).  We performed a 
similar analysis to examine the association between smoking status and selected survey 
respondents characteristics by asthma status and presented the results in Table 3.   Percentage of 
smokers among adults with and without asthma was estimated for each state by, adjusting for 
sex, age, and race and results are presented in Table 4.  
We tested for and found no multicollinearity among independent variables.  For instance, 
the two independent variables, education and income, did not have a high correlation.  P-value of 
27 
 
 
 
0.05 or less and not overlapping confidence interval (Gelman, 2000) are considered to be 
statistically significant.   
For the purposes of this analysis, demographic variables were re-coded in a variety of 
ways that differed from the original coding of the data. The recoding structure is illustrated in 
Table 1.  Specifically, age, race, education level, household income, and smoking status were re-
coded to form more condensed and representative groups found within the study population. 
Table 1 Initial and Re-coded Demographic Information 
Characteristics Initial Coding Re-coded 
Age 18-34- 18-24 
25-34- 25-34 
35-44- 35-44 
45-54- 45-54 
54-64- 54-64 
64-99- 64 or older 
BLANK- Not asked or missing 
1- 18-34 
2- 35-44 
3- 45-54 
4- 55-64 
5- 65+ 
 
Race 1- White 
2- Black or African American 
3- Asian 
4- Native Hawaiian or Other Pacific 
Islander 
5- American Indian, Alaska Native 
6- Other 
7- Don’t know/Not sure 
8- Multiracial but preferred race not 
asked 
9- Refused 
BLANK-Not asked or missing 
1- White 
2- Black 
3- AI/AN 
4- Asian/Pacific Islander 
5- Hispanic 
6- Other 
Hispanic/Latino 1- Yes 
2- No 
7- Don’t know/Not sure 
9- Refused 
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Education level 1- Never attended school or only 
kindergarten 
2- Grades 1 through 8 (Elementary) 
3- Grades 9 through 11(Some high 
school) 
4- Grades 12 or GED (High school 
graduate 
5- College 1 year to 3 years (Some 
college or technical school) 
6- College 4 years or more (College 
graduate) 
9- Refused 
BLANK- Not asked or Missing 
1- High School (HS) 
graduate or less 
2- Some college 
3- College 4 years or 
more 
Household 
income 
1- Less than $10,000 
2- Less than $15,000 ($10,000 to less 
than $15,000) 
3- Less than $20,000 ($15,000 to less 
than $20,000) 
4- Less than $25,000 ($20,000 to less 
than $25,000) 
5- Less than $35,000($25,000 to less 
than $35,000) 
6- Less than $50,000($35,000 to less 
than $50,000) 
7- Less than $75,000 ($50,000 to less 
than $75,000) 
8- $75,000 or more 
77- Don’t know/Not sure 
99- Refused 
BLANK- Not asked or Missing 
1- <15,000 
2- 15,000-24,999 
3- 25,000-49,999 
4- 50,000-74,999 
5- ≥75,000 
Smoking status 1- Current smoker- now smokes 
every day 
2- Current smoker- now smokes 
some days 
3- Former smoker 
4- Never smoked 
9- Don’t know/ Refused/ Missing 
1- Current smoker 
2- Former smoker 
3- Non-smoker 
Asthma status Lifetime Asthma: Combined: 
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1- No  
2- Yes 
9- Don’t know/Refused/ Missing 
1- No 
2- Yes 
Current Asthma: 
1- No 
2- Yes 
9-Don’t know/Refused/ Missing 
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CHAPTER IV 
 
RESULTS 
 
Results from the BRFSS dataset and ALA analysis are explained below.  The results presented 
address the three research questions posed at the onset of the study and outlined in chapter one of 
this paper. 
 
4.1 Characteristics of survey respondents 
After recoding the demographic variables from initial categories, frequency statistics were run on 
the following demographic markers: gender, age, race, highest level of education and income and 
on smoking status.  Table 2 presents the overall demographic characteristics of the survey 
participants, as well as the current asthma prevalence by demographic and socioeconomic 
variables. For the period 2009-2010, a total of 869,519 respondents from 50 states and  the 
District of Columbia (DC) were included in the analyses. Of those, 51% were female, mostly 
white (69%), 35% had an education level that was equivalent to a 4 year college or more, and 
nearly 18% were smokers.   
4.2 Asthma prevalence and factors associated with asthma 
Consistent with the previous CDC reports, our findings indicate that asthma status is 
significantly associated with all selected demographic and socioeconomic characteristics of the 
survey respondents (Table 2). The p-values for the chi-square test for independence to determine 
whether there is a significant relationship between two categorical variables was less than 0.0001 
in all the categories analyzed.  Results of frequency statistics are further depicted in Table 2. 
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Average annual current asthma prevalence was 8.5%. Consistent with the previous CDC reports, 
asthma prevalence rate was higher in females than males (10.5% compared with 6.4%).  The 
current asthma prevalence for each age group were significantly higher than the reference age 
group (aged 65+ years), however the highest was among adults aged 18-34 (9.3%; adjusted 
prevalence rate ratio [aPR]=1.4) (Table 2).  Among race/ethnic groups, current asthma 
prevalence was high among other races (13.5%), followed by American Indian/ Alaskan Native 
(13.0%), Black (10.0%), White (8.6%), Hispanic (6.7%), and finally Asian (4.8%).  Also, 
persons with some college degree (9.3%; [aPR]=1.1) and those in the lowest income bracket 
(13.3%; [aPR]=1.9) had the highest current asthma prevalence in their respective categories.  
Smoking status is significantly associated with current asthma status. Asthma prevalence was 
higher among both current (10.5%; [aPR]=1.2) and former smokers (8.8%; [aPR]=1.2) compared 
with non-smokers (7.8%; [aPR]=1.0).    
Table 2 Characteristics of adult survey respondents— 2009–2010 Behavioral Risk Factor 
Surveillance System data 
 Total  Characteristics of 
Survey 
Respondents 
Current Asthma 
Prevalence1 
Prevalence Rate 
Ratio 
 Sample size2  % (95% CI) % (95% CI) aPR (95% CI)3 
Total 869519 100 (0–0) 8.5 (8.4–8.6)  
Sex   p<0.00014  
   Male 329080 48.7 (48.5–48.9) 6.4 (6.3–6.6) 1.0 (reference) 
   Female 540439 51.3 (51.1–51.5) 10.5 (10.3–10.7) 1.6 (1.6–1.7) 
Age, year range   p<0.0001  
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   18–34 95841 28.2 (28.0–28.5) 9.3 (9.0––9.6) 1.4 (1.3–1.4) 
   35–44 116615 20.2 (20.1–20.4) 7.8 (7.6–8.1) 1.2 (1.2–1.3) 
   45–54 170300 19.5 (19.3–19.6) 8.4 (8.2–8.7) 1.3 (1.2–1.3) 
   55–64 194791 14.7 (14.6–14.8) 9.0 (8.8–9.2) 1.3 (1.2–1.3) 
   65+ 284209 17.4 (17.2–17.5) 7.8 (7.6–7.9) 1.0 (reference) 
Race(non-
Hispanic)/ 
Ethnicity  
  p<0.0001  
   White 690022 69.2 (69.0–69.4) 8.6 (8.5–8.8) 1.0 (reference) 
   Black  68024 10.2 (10.0–10.3) 10.0 (9.6–10.5) 1.0 (1.0–1.1) 
   AI/AN5 11961 1.1 (1.0–1.1) 13.0 (11.7–14.5) 1.3 (1.2–1.5) 
   Asian/Pacific 
Islander 
15899 3.8 (3.7–3.9) 4.8 (4.2–5.5) 0.6 (0.5–0.7) 
   Hispanic 53732 13.6 (13.4–13.8) 6.7 (6.3–7.1) 0.7 (0.6–0.7) 
   Other race 18973 2.2 (2.1–2.3) 13.5 (12.5–14.5) 1.4 (1.3–1.6) 
Education level   p<0.0001  
   High School 
(HS) graduate 
or less 
340602 38.4 (38.2–38.6) 9.1 (8.9–9.3) 1.0 (1.0–1.1) 
   Some college 232036 26.3 (26.1–26.5) 9.3 (9.1–9.6) 1.1 (1.1–1.1) 
   College 4 
years or more 
293834 35.3 (35.1–35.5) 7.3 (7.1–7.5) 1.0 (reference) 
Household 
Income 
  p<0.0001  
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   <$15000 86389 10.4 (10.2–10.5) 13.3 (12.8–13.8) 1.9 (1.8–2.0) 
   $15000–
$24999 
133940 15.8 (15.6–16.0) 10.3 (9.9–10.6) 1.5 (1.4–1.6) 
   $25,000–
$49999 
205802 24.6 (24.4–24.8) 8.1 (7.9–8.4) 1.2 (1.1–1.2) 
   $50000–
$74999 
120544 16.0 (15.9–16.2) 7.7 (7.4–8.0) 1.1 (1.0–1.2) 
   ≥$75000 202340 33.2 (32.9–33.4) 6.8 (6.6–7.0) 1.0 (reference) 
Smoking status   p<0.0001  
   Current 
smoker 
139086 17.6 (17.4–17.8) 10.5 (10.2–10.9) 1.2 (1.2–1.3) 
   Former 
smoker 
263614 24.9 (24.7–25.1) 8.8 (8.6–9.0) 1.2 (1.2–1.2) 
   Non-smoker 461190 57.5 (57.3–57.7) 7.8 (7.7–8.0) 1.0 (reference) 
1Includes persons who answered “yes” to the questions: “Have you ever been told by a doctor, nurse, or other health 
professional that you had asthma?” and “Do you still have asthma?” 
2Sample size (unweighted) for the corresponding subpopulations 
3Prevalence rate ratio (95% confidence interval) adjusted for age, sex, race, ethnicity, education, income, smoking.  
4P-values for the chi-square test for independence to determine whether there is a significant relationship between 
two categorical variables. 
5American Indian/ Alaskan Native 
4.3 Smoking rate by selected characteristics among adults with and without asthma 
Following the establishment of baseline demographic characteristics of BRFSS 
respondents and asthma status among them, we further examined smoking rate among those with 
and without asthma and identify the factors associated with high smoking rate (Table 3). Cross 
comparison between adults with asthma and adults without asthma, smoking rate was higher 
among those with asthma (21.7%) than those without asthma (17.2%). Comparison between the 
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different sub-group within adults with asthma and adults without asthma indicate that same 
demographic characteristics have the high smoking rate. Regardless of asthma status, smoking 
rates are higher among males than females, ages 18-34, 35-44, 45-54, 55-64 than ages 65+; 
American Indian/Alaska Native (AI/AN) and other race than whites; adults with high school or 
less education and adults with some college education than adults with 4 years or more college 
education, and among all adults with income of less than $75,000 than adults with higher income 
(>=$75,000) (Table 3). Worth noting that, smoking rates are lower among blacks, Asian/Pacific 
Islander, and Hispanic for both adults with asthma and without asthma, compared with whites. 
For example, percentage of smoking was 23.4% for adult males with asthma and 19.3% for adult 
males without asthma. Both rate for males were higher than rates for females (20.7% vs. 15.1%) 
(Table 3).   
Table 3 Percentage of smokers by asthma1 status and selected demographic characteristics— 
2009–2010 Behavioral Risk Factor Surveillance System data 
 Adults with asthma  
(n=78,159) 
Adults without asthma 
(n=783,417) 
 Percentage of smokers (n=15,597) Percentage of smokers 
(n=123,090) 
 % (95% CI) aPR (95% CI)2 % (95% CI) aPR (95% CI) 
Total 21.7 (21.1-22.4)  17.2 (17.0-17.4)  
Sex     
   Male 23.4 (22.2-24.7) 1.0 (reference) 19.3 (19.0-19.6) 1.0 (reference) 
   Female 20.7 (20.0-21.4) 0.9 (0.8-0.9) 15.1 (14.9-15.3) 0.8 (0.8-0.8) 
Age, year range     
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   18–34 26.1 (24.5-27.7) 3.0 (2.8-3.3) 21.5 (21.1-22.0) 3.1 (3.0-3.2) 
   35–44 22.9 (21.5-24.4) 3.2 (2.9-3.5) 17.7 (17.3-18.1) 3.0 (2.9-3.2) 
   45–54 25.1 (23.9-26.3) 3.2 (2.9-3.4) 19.6 (19.2-19.9) 3.1 (3.0-3.2) 
   55–64 19.6 (18.6-20.7) 2.4 (2.2-2.6) 16.2 (15.9-16.5) 2.5 (2.4-2.5) 
   65+ 9.9 (9.3-10.6) 1.0 (reference) 8.2 (8.0-8.4) 1.0 (reference) 
Race(non-Hispanic)/ 
Ethnicity  
    
   White 21.4 (20.7-22.1) 1.0 (reference) 17.5 (17.3-17.7) 1.0 (reference) 
   Black  22.9 (20.9-25.0) 0.8 (0.7-0.9) 19.2 (18.6-19.9) 0.8 (0.8-0.9) 
   AI/AN3 40.4 (34.7-46.4) 1.4 (1.2-1.6) 31.9 (29.7-34.2) 1.3 (1.2-1.4) 
   Asian/Pacific 
Islander 
9.7 (6.2-14.8) 0.6 (0.4-0.9) 9.4 (8.3-10.6) 0.6 (0.5-0.7) 
   Hispanic 19.2 (17.0-21.7) 0.6 (0.5-0.7) 14.4 (13.7-15.1) 0.5 (0.5-0.5) 
   Other race 31.1 (27.5-34.9) 1.1 (1.0-1.3) 24.8 (23.3-26.4) 1.2 (1.1-1.2) 
Education level     
   High School (HS) 
graduate or less 
 
31.3 (30.1-32.4) 
 
2.6 (2.3-2.8) 
 
24.4 (24.1-24.8) 
2.5 (2.4-2.5) 
   Some college 22.2 (21.0-23.4) 2.0 (1.8-2.2) 19.1 (18.7-19.5) 2.0 (1.9-2.0) 
   College 4 years or 
more 
8.3 (7.6-9.0) 1.0 (reference) 8.2 (8.0-8.5) 1.0 (reference) 
Household Income     
   <$15000 36.7 (34.8-38.7) 3.1 (2.8-3.5) 27.2 (26.4-27.9) 2.3 (2.2-2.4) 
   $15000–$24999 31.8 (30.1-33.6) 2.9 (2.5-3.2) 25.4 (24.8-26.0) 2.2 (2.1-2.2) 
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1Includes persons who answered “yes” to the questions: “Have you ever been told by a doctor, nurse, or other health 
professional that you had asthma?” and “Do you still have asthma?” 
2Prevalence rate ratio (95% confidence interval) adjusted for age, sex, race, ethnicity, education, income, smoking. 
3American Indian/ Alaskan Native 
4.4 Adjusted smoking rate by asthma status for each state 
After assessing the asthma and smoking status by demographic and socioeconomic 
variables, the percentage of smokers among adults by asthma status and state was examined. A 
sample size of 869,519 respondents was collected and the percent smokers for each state was 
estimated by adjusting for sex, age and race.  Overall, the analysis of all 50 states shows that the 
percentage of adult smokers who have asthma is significantly higher than the percentage of adult 
smokers without asthma. The U.S. total includes all 50 states plus DC and excludes the three 
territories (Guam, Virgin Island, and Puerto Rico).  Of all the states, 24 were found to have 
higher rates of adults with asthma who smoke than adults without asthma who smoke.  The states 
that were found to have higher rates of smoking adults with asthma are indicated with an asterisk 
in the ‘Adults with asthma who smoke’ percentage column (Table 4). Among states, the lowest 
percentage of smokers among adults with asthma was in Utah at 11.2% . Of the 50 states, 
Alabama, Arkansas, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, Mississippi, South 
Carolina, Tennessee, and West Virginia had the highest smoking rate as seen in Map as top 20%. 
Arkansas (+9.1%), Kentucky (+9.6%), Mississippi (+7.6%), South Carolina (+8.3%), and 
   $25,000–$49999 22.6 (21.2-24.1) 2.2 (1.9-2.5) 20.0 (19.6-20.5) 1.7 (1.6-1.8) 
   $50000–$74999 14.7 (13.3-16.1) 1.5 (1.3-1.7) 15.3 (14.8-15.7) 1.3 (1.3-1.4) 
   ≥$75000 8.4 (7.6-9.3) 1.0 (reference) 10.3 (10.0-10.5) 1.0 (reference) 
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Tennessee (+9.0%) had the largest positive percentage difference between adults with asthma 
who smoke and adults without asthma who smoke (Table 4).  
Table 4 Percentage of smokers among adults by asthma1 status and states— 2009–2010 
Behavioral Risk Factor Surveillance System data 
 Total Adults with asthma 
who smokes 
(n=15,597) 
Adults without 
asthma who smokes 
(n=123,090) 
 Sample 
size2  
%3 (95% CI))3 %3 (95% CI))3 %3 (95% CI))3 
U.S. 
Total4 
869519   *21.4 (20.8-22.1) 17.3 (17.1-17.5) 
AL 14457 22.1 (21.0-23.2) 26.2 (22.6-30.1) 22.0 (20.9-23.2) 
AK 4396 17.2 (15.5-19.0) 23.4 (16.7-31.8) 20.1 (18.2-22.2) 
AZ 11231 15.7 (14.4-17.1) 16.3 (12.5-20.9) 15.6 (14.2-17.1) 
AR 8036 21.8 (20.3-23.4) *30.6 (25.1-36.8) 21.5 (20.0-23.2) 
CA 35170 13.3 (12.7-13.9) *16.2 (14.2-18.4) 12.2 (11.6-12.7) 
CO 23619 16.2 (15.4-17.0) 15.4 (12.8-18.4) 16.6 (15.8-17.5) 
CT 13272 14.5 (13.5-15.5) 16.1 (12.8-20.1) 14.2 (13.2-15.4) 
DE 8607 17.7 (16.5-19.0) *23.2 (18.8-28.2) 17.3 (16.0-18.7) 
DC 7880 14.9 (13.8-16.1) 15.2 (12.1-18.9) 15.6 (14.4-16.9) 
FL 47164 18.1 (17.3-19.0) 19.6 (16.8-22.8) 17.0 (16.1-17.9) 
GA 11684 17.0 (16.0-18.2) 21.2 (17.0-26.1) 17.5 (16.3-18.7) 
HI 13235 16.5 (15.4-17.8) 16.6 (13.8-19.8) 14.8 (13.8-15.8) 
ID 12399 15.5 (14.5-16.5) 17.8 (14.7-21.4) 15.9 (14.9-17.0) 
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IL 11047 17.8 (16.7-18.9) 18.5 (14.9-22.6) 17.6 (16.5-18.8) 
IN 19507 21.6 (20.7-22.6) *26.9 (23.9-30.2) 21.8 (20.8-22.8) 
IA 12126 16.5 (15.5-17.5) *22.4 (18.8-26.4) 16.2 (15.2-17.2) 
KS 27482 17.0 (16.3-17.7) *21.5 (18.8-24.4) 17.0 (16.3-17.8) 
KY 17713 24.6 (23.4-25.8) *34.0 (30.2-38.2) 24.4 (23.1-25.7) 
LA 15914 21.1 (20.1-22.1) 25.8 (21.5-30.7) 21.8 (20.8-22.8) 
ME 16214 17.7 (16.8-18.6) 20.8 (18.1-23.6) 17.5 (16.6-18.4) 
MD 17776 15.1 (14.2-16.0) *20.1 (16.7-24.0) 14.9 (14.0-15.8) 
MA 33042 14.7 (14.0-15.3) *18.9 (16.8-21.2) 14.0 (13.3-14.7) 
MI 18118 18.8 (18.0-19.7) 21.0 (18.3-24.0) 19.1 (18.2-20.1) 
MN 14579 15.3 (14.4-16.4) 16.1 (12.6-20.4) 15.8 (14.8-16.9) 
MS 19283 22.3 (21.3-23.3) *30.3 (26.8-34.0) 22.7 (21.7-23.8) 
MO 10486 21.4 (20.2-22.8) 25.2 (20.6-30.5) 21.8 (20.5-23.2) 
MT 14922 16.9 (15.9-18.0) *24.1 (20.2-28.5) 17.3 (16.2-18.5) 
NE 32377 16.6 (15.6-17.6) 17.5 (14.2-21.3) 17.0 (16.0-18.1) 
NV 7753 21.4 (19.8-23.2) 23.0 (18.0-28.8) 21.6 (19.8-23.4) 
NH 12035 15.9 (14.9-16.9) 17.3 (14.6-20.5) 16.1 (15.0-17.2) 
NJ 24828 15.7 (15.0-16.5) 16.0 (13.7-18.5) 15.1 (14.3-15.9) 
NM 15834 18.2 (17.2-19.4) 20.9 (17.3-25.1) 18.0 (16.9-19.1) 
NY 15877 17.3 (16.5-18.3) *21.6 (18.7-24.8) 16.4 (15.4-17.3) 
NC 25416 19.5 (18.6-20.4) 23.5 (20.5-26.9) 19.8 (18.9-20.8) 
ND 9530 16.9 (15.8-18.0) 20.6 (16.8-25.0) 17.7 (16.5-19.0) 
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*Percentage of smokers among adults with asthma was greater than the percentage of smokers among adults who 
does not have asthma  
1Includes persons who answered “yes” to the questions: “Have you ever been told by a doctor, nurse, or other health 
professional that you had asthma?” and “Do you still have asthma?” 
2Sample size (unweighted) for the corresponding subpopulations 
3Adjusted for sex, age, and race/ethnicity 
4U.S. Total includes 50 states plus DC and excludes the three territories 
 
 
 
OH 19631 21.0 (20.1-21.9) *26.5 (23.2-30.0) 20.9 (20.0-21.9) 
OK 15590 22.7 (21.7-23.6) *29.9 (26.7-33.4) 24.0 (23.0-25.0) 
OR 9360 15.7 (14.6-17.0) *23.4 (19.2-28.1) 15.8 (14.6-17.1) 
PA 20415 19.6 (18.7-20.4) *24.2 (21.4-27.2) 18.8 (17.9-19.7) 
RI 12895 15.3 (14.3-16.3) 16.0 (13.2-19.3) 15.4 (14.4-16.5) 
SC 19293 20.0 (18.9-21.2) *28.4 (23.5-34.0) 20.1 (18.9-21.3) 
SD 13552 15.4 (14.4-16.4) 17.6 (14.4-21.2) 16.4 (15.3-17.5) 
TN 11346 20.8 (19.6-22.1) *29.5 (24.6-35.0) 20.5 (19.2-21.8) 
TX 29685 17.4 (16.5-18.4) *22.2 (19.0-25.8) 16.6 (15.7-17.6) 
UT 20334 08.8 (08.2-09.4) 11.2 (9.2-13.6) 9.3 (8.7-10.0) 
VT 13462 15.9 (15.0-16.8) *21.3 (18.3-24.7) 15.6 (14.7-16.6) 
VA 10576 18.5 (16.9-20.2) 24.2 (19.7-29.5) 18.4 (16.7-20.2) 
WA 39922 14.7 (14.1-15.2) *18.6 (16.6-20.7) 14.7 (14.1-15.3) 
WV 9218 26.1 (24.9-27.3) *32.8 (28.5-37.4) 25.6 (24.3-26.9) 
WI 9334 18.3 (17.0-19.8) *25.0 (20.1-30.6) 18.3 (16.9-19.9) 
WY 11897 18.9 (17.9-20.0) 21.1 (17.7-25.0) 19.7 (18.5-20.8) 
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Map1. Percentage of smokers among adults with asthma by state 
 
4.5 Adjusted smoking rate among adults with asthma and level of tobacco control by states  
After examining the percentage of smokers among adults by asthma status and state, the 
smoking rate among adults with asthma as it relates to different measure of tobacco control was 
analyzed by state.  Data from the ALA 2008 report that tracks progress on key tobacco control 
policies at the state level were used to create Table 5. In Table 5, for each state, we presented 
adjusted (by age, sex, and race) smoking prevalence rate among adults with asthma and data 
from the ALA 2008 report on the three policies- smoke-free air (total score, grade), cigarette 
excise tax (tax rate per pack of 20 cigarettes, grade), and cessation coverage (total score, grade).  
We calculated, the ‘Overall Policy Grade’ column, which is the cumulative grade of all policies 
implemented by using the scores for grades as A=4, B=3, C=2, D=1, F=0. Tables 6 and 7 take a 
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closer look at the states with the highest and lowest smoking rates for adults with asthma and 
overall smoke-free policy grade as indication of state of tobacco control efforts to examine the 
association between them. 
Table 5 Percentage of adults with asthma who smoke and level of tobacco control by state. 
  Level of tobacco control 
  Smokefree Air 
Grading1 
Cigarette Excise 
Tax overview1 
Cessation Coverage 
Grading1 
Overall 
Policy 
Grade 
State  %  Adults 
with 
asthma 
who 
smoke2 
Total 
Score 
Grade Tax Rate 
(per 
pk.of 20) 
Grade Total 
Score 
Grade  
AL 26.2 20 F $0.425 F 17 F 0 
AK 23.4 21 F $2.00 B 19 F 3 
AZ 16.3 46 A $2.00 B 26 D 8 
AR* 30.6 36 B $0.59 F 28 D 4 
CA 16.2 40 A $0.87 D 28 D 6 
CO 15.4 40 A $0.84 D 21 F 5 
CT 16.1 39 C $2.00 B 5 F 5 
DE* 23.2 46 A $1.15 D 15 F 5 
DC 15.2 36 A $2.00 B 28 D 8 
FL 19.6 41 B $0.339 F 21 F 3 
GA 21.2 31 C $0.37 F 3 F 2 
HI 16.6 43 A $2.00 B 21 F 7 
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ID 17.8 36 B $0.57 F 21 F 3 
IL 18.5 48 A $0.98 D 29 C 7 
IN* 26.9 7 F $0.995 D 30 C 3 
IA* 22.4 42 A $1.36 C 18 F 6 
KS* 21.5 16 F $0.79 D 18 F 1 
KY* 34 3 F $0.30 F 18 F 0 
LA 25.8 36 B $0.36 F 16 F 3 
ME 20.8 42 A 2.00 B 29 C 9 
MD* 20.1 42 A $2.00 B 14 F 7 
MA* 18.9 42 A $2.51 A 29 C 10 
MI 21 17 F $2.00 B 21 F 3 
MN 16.1 41 A $1.504 C 35 B 9 
MS* 30.3 11 F $0.18 F 25 D 1 
MO 25.2 16 F $0.17 F 4 F 0 
MT* 24.1 35 I3 $1.70 C 18 F 2 
NE 17.5 18 I4 $0.64 D 30 C 3 
NV 23 37 B $0.80 D 32 C 6 
NH 17.3 33 D $1.33 C 22 F 3 
NJ 16 41 A $2.575 A 24 F 8 
NM 20.9 40 A $0.91 D 33 B 8 
NY* 21.6 43 A $2.75 A 24 F 8 
NC 23.5 6 F $0.35 F 24 F 0 
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*Percentage of smokers among adults with asthma was greater than the percentage of smokers among adults who 
does not have asthma  
1SOURCE: American Lung Association. State of Tobacco Control 2008 http://www.lung.org/about-
us/publications/index.html#presidents-report  
2Adjusted for sex, age, and race/ethnicity 
3Montana gets an “I” for Incomplete because they passed a smokefree law in 2005, but parts of it were delayed from 
taking effect until October 1, 2009.  
4Nebraska gets an “I” for Incomplete because they passed a smokefree law in 2008, but it does not take effect until 
June 1, 2009. 
 
 
ND 20.6 32 C $0.44 F 33 B 5 
OH* 26.5 44 A $1.25 C 23 F 6 
OK* 29.9 34 D $1.03 D 24 F 2 
OR* 23.4 45 A $1.18 D 34 B 8 
PA* 24.2 36 C $1.35 C 32 C 6 
RI 16 41 A $2.46 A 36 B 11 
SC* 28.4 10 F $0.07 F 19 F 0 
SD 17.6 30 F $1.53 C 15 F 2 
TN* 29.5 34 C $0.62 D 6 F 3 
TX* 22.2 9 F $1.41 C 18 F 2 
UT 11.2 41 A $0.695 D 21 F 5 
VT* 21.3 36 A $1.99 B 22 F 7 
VA 24.2 13 F $0.30 F 23 F 0 
WA* 18.6 47 A $2.025 B 24 F 7 
WV* 32.8 7 F $0.55 F 21 F 0 
WI* 25 16 F $1.77 C 33 B 5 
WY 21.1 0 F $0.60 D 19 F 1 
44 
 
 
 
 
4.5 Evaluating the association between the level of tobacco control and smoking rate among 
adults with asthma by states  
We examined the association between the smoking rate among adults with asthma and 
measure of state of tobacco control efforts among states. Smoking rates for states were divided 
into five quintiles and overall policy grade, mean, minimum, and maximum values of overall 
tobacco control policy grade for states in each 5 quintile were calculated (Table 6).  To show the 
impact that tobacco control had on smoking rate, we performed t-test to examine if mean tobacco 
control policy grades for states in quintile 1(Q1) to Q4 were significantly different than the mean 
tobacco control policy grade for states with the highest smoking rate (Q5=highest 20%).  The 
mean tobacco control policy grade was calculated based on the three tobacco control laws.  We 
assigned a grade point by giving 4 points for grade A, 3 points for B, 2 points for C, 1 point for 
D, and 0 points for F.  Then the points for the 3 components were summed to derive the total 
points (overall policy grade) for each state.  The total points ranges from zero to 12. The higher 
the overall policy grade, the better the tobacco control effort in the state. The mean tobacco 
control policy grade for states in Q1, Q2, and Q3 groups were significantly higher than the grade 
for states in Q5 with a p-value less than 0.05.  
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Table 6 Percentiles of smoking rate (adjusted for sex, age, and race) among adults with asthma 
and corresponding grades for tobacco control status 
 
*Mean grades for the two groups are significantly different (t-test: p-value <0.05) 
 
In addition to measuring the effects of tobacco control measures nationwide, the states 
with the lowest and highest smoking rates among adults with asthma were identified and listed in 
Table 7.  Table 7 shows that none of the states in the lowest quintile have an asterisk next to their 
name, indicating that the percentage of adult smokers with asthma is not greater than the 
percentage of adult smokers who do not have asthma. On the other hand, nine out of the eleven 
states listed in the highest quintile column have an asterisk next to their name.  The states in the 
lowest quintile (5-11) had an overall policy grade range that was significantly higher than the 
states in the highest quintile (0-4) (t-test: p-value <0.00001).  Also, the ranges of smoking rates 
 Quintiles of smoking rate among adults with asthma (20% of states in 
each quintile based on smoker percentages) 
Smoking Rate Q1 (lowest = 
11.2%-
16.7%) 
Q2 (second = 
17.0%-
20.7%) 
Q3 (middle = 
20.8%-
22.9%) 
Q4 (fourth = 
23.0%-
25.7%) 
Q5 (highest 
= 25.8%-
34.0%) 
Overall Policy 
Grade 
72 50 47 35 22 
Range (min-max 
grade) 
5-11 2-10 1-9 0-8 0-6 
Mean grade (std 
dev) 
7.2 (1.99) 5.0 (2.62) 4.7 (3.20) 3.5 (2.92) 2.0 (2.00) 
 T-test Q1 vs. Q5 Q2 vs. Q5 Q3 vs. Q5 Q4 vs. Q5  
P-value 0.0000* 0.0096* 0.0369* 0.1925  
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in the lowest (11.2-16.6) and highest quintiles (25.8-34.0) were found to be statistically 
significant. 
Table 7 Evaluating the tobacco control status of states with the lowest and highest smoking rates 
(adjusted for sex, age, and race) among adults with asthma   
Note: none of the lowest states have asterisk next to the name. 
The states with the lowest smoking rates 
among adults with asthma (below 20th 
percentile of 17.0%) 
The states with the highest smoking rates 
among adults with asthma (80th percentile 
of 25.8% and above) 
State % Smokers Overall 
Policy Grade 
State % Smokers Overall 
Policy Grade 
UT 11.2 5 LA 25.8 3 
DC 15.2 8 AL 26.2 0 
CO 15.4 5 OH* 26.5 6 
NJ 16.0 8 IN* 26.9 3 
RI 16.0 11 SC* 28.4 0 
CT 16.1 5 TN* 29.5 3 
MN 16.1 9 OK* 29.9 2 
CA 16.2 6 MS* 30.3 1 
AZ 16.3 8 AR* 30.6 4 
HI 16.6 7 WV* 32.8 0 
   KY* 34.0 0 
Total grade  72   22 
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*Mean grades for the two groups are significantly different (t-test: p-value <0.00001) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mean (std 
dev)* 
 7.2 (1.99)   2.0 (2.0) 
Range (11.2-16.6) (5-11)  (25.8-34.0) (0-4) 
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CHAPTER V 
 
DISCUSSION AND CONCLUSION 
5.1 Discussion 
The first effort to educate the public on the harmful effects of second hand smoking was in 
1971 when Surgeon General Jesse Steinfeld suggested that low-dose exposure to cigarette smoke 
may have a potential public health risk for nonsmokers (Institute, 2000).  Fifteen years later, in 
1986, Surgeon General Dr. Koop released a report The Health Consequences of Involuntary 
Smoking. The report included the following: 
“Involuntary smoking is a cause of disease, including lung cancer, in health nonsmokers. 
The children of parents who smoke compared with the children of nonsmoking parents 
have an increased frequency of respiratory infections, increased respiratory symptoms, 
and slightly smaller rates of increase in lung function as the lung matures. 
The simple separation of smokers and nonsmokers within the same air space may reduce, 
but does not eliminate, the exposure of nonsmokers to environmental tobacco 
smoke.”(Institute, 2000) 
After the publication of Dr. Koop’s report, federal agencies started taking steps to 
educate the public on the dangers of tobacco smoke to smokers as well as non-smokers.  One of 
the most significant steps taken by a federal agency came in 1990 when the U.S. Environmental 
Protection Agency (EPA) released a publication Assessment on Environmental Tobacco Smoke 
(ETS) in which they classify tobacco smoke as a Group A carcinogen that can cause lung cancer 
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in nonsmokers (Institute, 2000).  Since then, a multitude of reviews conducted by medical and 
governmental organizations leave no doubt that environmental tobacco smoke causes disease in 
smokers and non-smokers.  The health effects associated with exposure to ETS include: 
developmental (fetal growth and sudden infant death syndrome), respiratory (acute lower 
respiratory tract infections in children, asthma induction and exacerbation in children, chronic 
respiratory symptoms in children, eye and nasal irritation in adults, and middle ear infections in 
children), carcinogenic effects (lung cancer and nasal sinus cancer), and cardiovascular effects 
(heart disease mortality and acute and chronic coronary heart disease morbidity) (Institute, 
2000). 
Multiple factors play a role in the development of asthma and the exacerbation of asthma 
symptoms. We examined the predictive ability of selected factors on asthma prevalence in the 
2009 and 2010 BRFSS data. We found that all selected potential predictive factors were 
significant predictors of current asthma for the overall study population. These findings are 
consistent with those of previous research (Zahran, 2012;Strine, 2004;Gwynn, 2004).  
Examining data from the ALA Tobacco Control Report of 2008 along with smoking rate in 
states, our findings indicate that states with better tobacco control policies/laws had lower 
smoking rate among adults with asthma than states that do not have.  
In order to combat this public health concern, the public health community has been involved 
in policies that have a more comprehensive approach designed to change environmental and 
social norms.  The findings of this paper show evidence of significant association between 
smoking and asthma status and lower smoking prevalence rate among adults with asthma in 
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states with three tobacco control interventions.  This study was unusual in specifically linking 
national reduced smoking prevalence among adults with asthma with an increasing tobacco 
control measures (smoke-free environment, cigarette excise tax and cessation coverage) as 
opposed to specific community based efforts (Dockery, 1993;Juster, 2007;Head, 2012;Roberts, 
2012;Huang, 2012) and specific tobacco control policies (Juster, 2007;Roberts, 2012;Huang, 
2012;Wakefield, 2008;Kabir, 2009;Jill S. Rumberger, 2010;Dilley, 2012).  The study also 
furnished great detail on the link between smoking prevalence and specifically asthma rates as it 
relates to policy which is lacking in research, most literature reviewed discuss the link between 
smoking prevalence and policy discounting the effect smoking has on asthma rates (Juster, 
2007;Roberts, 2012;Head, 2012;Huang, 2012;Wakefield, 2008;Kabir, 2009;Jill S. Rumberger, 
2010;Dilley, 2012).  While there is a wealth of research on cessation outcomes related to specific 
legislation measure, there is less research on population-level smoking prevalence. 
Although, the association between lower smoking rate and the implementation of the tobacco 
control policies and measures is based on state level evaluation (not based on individual data), 
nonetheless the findings clearly indicate a strong association, which brings the importance of 
government role in reducing smoking rate and related harmful health effects.   
Policy measures 
Among the three policy measures discussed in this study, Cigarette excise tax is the most 
controversial.  President Obama states that his proposal for a 94-cent federal tax increase ‘would 
have substantial public health benefits, particularly for young America’ (Budget, 2013).  This is 
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following the 62 cent tax increase in 2009 which effectively dropped cigarette sales by an 
estimated 10% (Huang, 2012).  This topic is controversial for two reasons. First, sales taxes are 
viewed as regressive because the higher income groups invest a smaller share of their income 
than the poor.  Second, since the prevalence of smoking is higher among the poor, cigarettes are 
disproportionately consumed by the poor.  While excise tax could have some sort of 
discriminatory selection because it is targeting the people who cannot afford to buy cigarettes.  
However, it is this sector of the community that is most affected by smoking rate and asthma 
based on statistics (Table 2 and 3).  Public health policy aims to treat behavioral change, the 
extent to which higher taxes cause smokers to quit or cut back on smoking. 
If the poor cut back enough relative to the rich, the smoking and asthma rates should be 
balanced in a way that will promote the policy’s impact as possible effective preventive measure.  
Some may argue that putting this additional burden on low income populations could also lead to 
some other unfavorable results like cutting back from their expense on food and other essential 
necessities and using the money to buy cigarettes which will create financial stress (Martire, 
2011).  However, if higher cigarette tax forces the poor in society to cut back on their 
consumption of cigarettes that will meet the goal of reducing overall smoking rate, exposure to 
second hand smoke as well as lessen the economic burden on the health care system brought on 
by smoking related diseases.  
It is important to note that, as demonstrated by Martire et al., the financial stress on 
responses to price increases may lower the quit rates among certain smokers.  Not all smokers 
among the poor population will respond the same to the increase in cigarette tax, some may 
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choose to quite in so doing they eliminate the financial burden of cigarette taxes.  Others may 
lessen their daily consumption and be left where they started spending the same amount yet 
consuming less.  The final group is that which will continue to smoke the same amount, spending 
more than they did previously and experiencing additional financial stress.  An approach that 
may prove beneficial is to create policy that will support smokers that are struggling to quit by 
providing them with free or subsidized smoking cessation resources that will reduce their 
economic burdens.  This approach has been implemented and appropriately funded in eight states 
as of 2011; according to the CDC’s Best Practices for Comprehensive Tobacco Control 
Programs the per capita recommended level of investment ranges from $9.23 to $18.02 based on 
state’s specific characteristics.  The report confirms that if states were to continue the level of 
investment for a 5 year time span, there would see the number of smokers decline by 5 million.   
An additional advantage to implementing and funding tobacco cessation programs is that 
fewer young adults (particularly in the 8th through 12th grade range) would smoke.  Tauras et al., 
published a study in the American Journal of Public Health in which they conclude that if states 
invested the CDC-recommended minimum level for tobacco control, the estimates for youth 
smoking prevalence would have been lowered by 3.5- 13.5% nationwide (Tauras, 2005).   
5.2 Study Limitations 
The use of BRFSS dataset is a great strength as it has been applied to research and evaluated 
by the CDC and participating states since 1984 (Prevention, 2011).  The content of the 
surveillance system which includes: designs of the questionnaire, survey questions, interviewing 
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methods, procedures for data collection and processing has been progressively developed over 
the past 29 years to improve data quality.  At large, statistics from the BRFSS is relied on and 
accurate. However, there were several limitations in this study. 
First, the BRFSS data is collected by telephone interviews.  Individuals who live in 
households without a residential telephone (1.7%) are not included (Prevention, 2011).  
Therefore, the BRFSS might exclude persons of lower socioeconomic status or households with 
cellular phones only (24.9%) (CDC, 2011).  Second, the survey is based on populations that are 
not institutionalized; thereby excluding persons residing elsewhere, such as nursing homes or 
long-term care facilities, this may affect the findings for older adults.  Third, the BRFSS data are 
self-reported by respondents and smoking status was not validated by biochemical tests. As a 
result, smoking maybe underreported because of social desirability bias.  Fourth, the sampling 
frame of the BRFSS is the entire state; therefore, some rural areas might be represented by 
relatively few interviews.  Finally, the study assumes that the full benefits of the tobacco control 
measures will be accrued within a year of implementation.  However, in reality, it may take years 
before individuals decide to change their smoking habits and for society to start reaping the 
economic and health benefits of lower smoking rates. 
5.3 Conclusion 
Our findings show that predictors of asthma differed by demographic characteristics. As in 
the results for whites and blacks, all selected potential factors (sex, age, education, income, and 
smoking status) were significant predictors of asthma prevalence in the overall adult population. 
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Also, shown in this study is the link between smoking status and asthma status nationwide as it 
affects different demographic groups in the population. Finally, we were able to show the link 
between smoking rate and state of tobacco control efforts. The study findings indicate that 
comprehensive policy measures have a significant impact on the smoking rate nationwide.  
Although most U.S. state smoke-free policies and regulations are relatively new, it is evident that 
that these laws are effective in promoting cessation among adults and reducing nonsmokers’ 
exposure to secondhand smoke.  The study found that smoke-free laws will improve health by 
lowering smoking rates among adult smoker that will in turn reduce harmful health effects due to 
smoking and exposure to secondhand smoke, including exacerbation of asthma symptoms.   
Further studies are warranted to track impact of interventions expected to affect smoking on 
the general population.  Observational studies with longitudinal design are needed to employ 
clear definitions of policy components and careful control for confounding.  These studies will 
be important in developing targeted interventions to reduce the health and economic impact of 
smoking among disproportionately affected segments of the United States population. 
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